Find what you need in the Fundación Valle del Lili

Are you looking for a medical service, a specialty, a healthcare professional, or information about appointments and programs?
Use our smart search engine to easily access everything that the Fundación Valle del Lili.

Services for you

Study to evaluate the change in disease status in adult participants with acute myeloid leukemia (AML) who received venetoclax oral tablets in combination with azacitidine injected subcutaneously (SC) or intravenously (IV) in Colombia-05587049

Study ID: 05587049

Efficacy and safety of venetoclax in combination with azacitidine in patients with acute myeloid leukemia in real-world clinical practice

About the study:

 

Inclusion criteria: * Newly diagnosed acute myeloid leukemia (AML), defined as participants with histological confirmation of AML (de novo, secondary) according to World Health Organization (WHO) criteria and who have not received prior treatment for AML. * Ineligible for intensive chemotherapy due to age 75 or older; or age 18 to 74 with comorbidities that preclude the use of intensive induction chemotherapy. * Participants initiating treatment with venetoclax in combination with azacitidine, treated according to the Colombian prescribing information, and who have not completed the first cycle (28-day cycle). Exclusion criteria: – Participation in an interventional clinical trial within 30 days prior to the start of treatment with venetoclax.

Total length

Target audiences

Ages: 18 - N/A years
Sex: All

Location

AbbVie

Associated diseases

  • AML
  • Adult Oncology

Request an appointment via WhatsApp
Request a call
Medical Directory
Check results
Contact